iFR Guided Coronary Artery Bypass Grafting Surgery
iCABG
Long-term Graft Patency Outcomes of LIMA-LAD Post-CABG Surgery Based on iFR Measurements.
1 other identifier
observational
100
1 country
1
Brief Summary
The expected outcome of better and improved patency of bypass grafts and its direct relation to pre-operative iFR measurements of stenosis as compared to direct visual physiology of stenosis in the coronary angiogram. To establish the correlation between the use of intracoronary physiology and improved graft patency at 12 months for patients undergoing CABG surgery. It is a minimum of 28 and a maximum of 100 patients single-centre proof or concept/ observational study/ pilot study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 4, 2019
CompletedFirst Posted
Study publicly available on registry
July 10, 2019
CompletedStudy Start
First participant enrolled
April 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2026
ExpectedNovember 21, 2023
November 1, 2023
3.4 years
July 4, 2019
November 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Graft patency
The primary endpoint will be graft patency as assessed by CT coronary angiography at 12 months.
12 months
Secondary Outcomes (8)
Quality of Life Questionnaire
3 and 12 months
Composite of MACE (MI, Death, stroke, repeat revascularisation)
12 months
Any episode of reintervention
12 months
Incidence of Myocardial infarction
12 months
Incidence of Stroke
12 months
- +3 more secondary outcomes
Study Arms (1)
Patients with multi-vessel coronary artery disease (MVCAD)
iFR measurements will be taken pre-operatively during the invasive coronary angiography.
Interventions
Patients with MVCAD will undergo CABG as per standard of care.
Eligibility Criteria
Retrospective cohort study - approximately 250 pts Prospective cohort study - minimum 28 pts - maximum 100 pts
You may qualify if:
- Age of 25 to 80 years of age
- Willing to participate and able to understand, read and sign the informed consent form (ICF) before standard of care elective CABG surgery
- Undergoing isolated first-time elective CABG surgery
- Available pre-operative angiography data with iFR measurements done during the pre-operative angiography
You may not qualify if:
- Emergency CABG surgery
- Ejection Fraction≤ 40%
- Severe valvular heart disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Prakash Punjabilead
Study Sites (1)
Imperial College Healthcare NHS Trust - Hammersmith Hospital
London, Greater London, W12 0HS, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Prakash P Punjabi, MBBS,MCh,FRCS,FFST,FESC,FCCP
Imperial College Healthcare NHS Trust
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Consultant Cardiothoracic Surgeon
Study Record Dates
First Submitted
July 4, 2019
First Posted
July 10, 2019
Study Start
April 25, 2022
Primary Completion
August 31, 2025
Study Completion (Estimated)
August 31, 2026
Last Updated
November 21, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- 36 months
- Access Criteria
- According to study protocol
Anonymised individual participant data for all primary and secondary outcome measures will be made available.